Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2026 Mar 1;16(1):59-65.
doi: 10.4103/mgr.MEDGASRES-D-24-00129. Epub 2025 Jun 28.

Gas mixture in noninvasive ventilation

Affiliations
Review

Gas mixture in noninvasive ventilation

Mostafa Elshazly et al. Med Gas Res. .

Abstract

Noninvasive ventilation (NIV) and high-flow nasal cannula are increasingly used to treat acute respiratory failure. Because many of these patients could also benefit from inhaled medications, combining aerosol therapy with NIV or high-flow nasal cannula is a promising approach. Effective drug delivery to the lungs is crucial for successful aerosol therapy during NIV. Prior research has identified several factors that affect aerosol delivery efficiency in NIV patients. Medical gases have a long history of use in managing various respiratory conditions. Among them, oxygen is frequently used for patients with hypoxia (e.g., hypoxemic respiratory failure and in newborns). In addition to deoxygenation, helium oxygen mixture and nitric oxide can also be administered through devices such as masks combined with NIV. This narrative review aims to provide a comprehensive overview on the application of gas mixtures (such as helium oxygen mixtures and nitric oxide) in NIV, focusing on their efficacy, safety, and optimization strategies in different clinical settings.

Keywords: aerosol drug delivery; drug delivery systems; gas mixtures; heliox; helium-oxygen mixture; inhalation therapy; inhaled nitric oxide; metered-dose inhaler; nebulizer; noninvasive ventilation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: All authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The recommended position for aerosol device is between the leak port and the mask. Created with OpenAI’s DALL·E under authors’ direct supervision to ensure scientific accuracy.
Figure 2
Figure 2
Full face mask.
Figure 3
Figure 3
Oronasal face mask. Oronasal face mask is often favored by clinicians.

References

    1. Xu XP, Zhang XC, Hu SL, et al. Noninvasive ventilation in acute hypoxemic nonhypercapnic respiratory failure: a systematic review and meta-analysis. Crit Care Med. 2017;45:e727–e733. - PMC - PubMed
    1. Madney YM, Laz NI, Elberry AA, Rabea H, Abdelrahim MEA. The influence of changing interfaces on aerosol delivery within high flow oxygen setting in adults: an in-vitro study. J Drug Deliv Sci Technol. 2020;55:101365.
    1. Harb HS, Saeed H, Madney YM, et al. Update efficacy of aerosol therapy with noninvasive ventilator approach (non-invasive ventilation and nasal high flow) J Drug Deliv Sci Technol. 2020;59:101922.
    1. Pollack CV, Jr., Fleisch KB, Dowsey K. Treatment of acute bronchospasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. Ann Emerg Med. 1995;26:552–557. - PubMed
    1. Brandao DC, Lima VM, Filho VG, et al. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma. J Asthma. 2009;46:356–361. - PubMed

LinkOut - more resources